| Takeda Pharma AG - Advate 250 U.I. (2 ml), Lyophilisat und Lösungsmittel zur intravenösen Injektion | | 56352 | | 07 | | Advate 250 U.I. (2 ml) | | Lyophilisat und Lösungsmittel zur intravenösen Injektion | | B02BD02 | | Coagulation Factor Viii | | 11.06.2012 | | |
| | Composition | | Praeparatio cryodesiccata: octocogum alfa 250 U.I., trehalosum dihydricum, histidinum, trometamolum, natrii chloridum, calcii chloridum dihydricum, polysorbatum 80, mannitolum, antiox.: glutathionum 0.4 mg, pro vitro.
Solvens: aqua ad iniectabile 2 ml. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Blutgerinnungsfaktor Viii Vom Menschen | 250 UI |
| | BAG: Active Agent | Dose |
|---|
| Octocogum alfa | 250 UI |
| | | | Inactive agents | Dose | additional_information |
|---|
| Calcium Chloride | | | | Glutathionum | 0.4 mg | antiox. | | Histidine | | | | Mannitol | | | | Sodium Chloride | | | | Polysorbatum 80 | | | | Trehalosum Dihydricum | | | | Trometamol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 017 | Set(s) | 181.59 | 227.35 | B | SL | Yes |
|
|
